Wnt pathway modulating antibodies (Surrozen)

N/A

Report date: 2025/03/20 09:55:52

Base Information

Drug NameWnt pathway modulating antibodies (Surrozen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCatenin beta 1 modulators
TargetsCatenin beta 1
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSurrozen Inc
China Registration ClassN/A

Develop Information

Active CompaniesSurrozen Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A